Global Strategy for Prevention, Diagnosis and Management of COPD: GOLD 2024 Report
AI-Generated Summary
Educational summary — always verify with primary sourceThe GOLD report is the internationally recognized evidence-based guideline for COPD diagnosis, staging, and management, updated annually.
Evidence-based guideline synthesis by an international expert panel.
GOLD 2024 key updates: (1) Refined ABCD grouping to ABE (E = exacerbation-prone); (2) Blood eosinophil count ≥300 guides ICS use; (3) Triple therapy recommended for Group E; (4) Lung cancer screening integration; (5) Updated exacerbation prevention strategies.
Know the GOLD ABE classification, spirometric grades (GOLD 1–4), and treatment escalation algorithm. Eosinophil-guided ICS use is now central to COPD management. All PCCM board candidates must know GOLD criteria and treatment pathways.
Guideline — not a clinical trial. Updated annually; always check current version.
Access the complete publication on PubMed